Modulation of the tumor vasculature and oxygenation to improve therapy

Pharmacology and Therapeutics

Volumn 153, Issue , 2015, Pages 107-124

  Siemann, Dietmar W ^a   Horsman, Michael R ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Exercise; Hypoxia modifiers; Metastases; Microenvironment; Stem cells; Vascular targeting

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; RADIOSENSITIZING AGENT; VASCULAR TARGETING AGENT;

ACIDITY; ADAPTATION; ARTICLE; BLOOD VESSEL; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CANCER THERAPY; CELL HYPOXIA; CELL POPULATION; CLINICAL TRIAL (TOPIC); EXERCISE; EXTRACELLULAR MATRIX; HEAD AND NECK CANCER; HUMAN; HYPERTHERMIA; HYPOXIA; METASTASIS POTENTIAL; MICROCIRCULATION; NASOPHARYNX CANCER; NEOPLASM; NONHUMAN; NUTRIENT; OXYGENATION; PATIENT CARE; PH; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; TISSUE PRESSURE; TREATMENT OUTCOME; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; METABOLISM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; HYPOXIA; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MICROENVIRONMENT;

EID: 84938420626     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.06.006     Document Type: Review

References (230)

1. G.E. Adams, and M.S. Cooke Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria Int J Radiat Biol Relat Stud Phys Chem Med 15 1969 457 471
2. G.E. Adams, I.R. Flockhart, C.E. Smithen, I.J. Stratford, P. Wardman, and M.E. Watts Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers Radiat Res 67 1976 9 20
3. G.O. Ahn, and M. Brown Targeting tumors with hypoxia-activated cytotoxins Front Biosci 12 2007 3483 3501
4. O. Alqawi, H.P. Wang, M. Espiritu, and G. Singh Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells Free Radic Res 41 2007 788 797
5. R.B. Armstrong, and M.H. Laughlin Rat muscle blood flows during high-speed locomotion J Appl Physiol 59 1985 1322 1328
6. K.M. Bae, Z. Su, C. Frye, S. McClellan, R.W. Allan, J.T. Andrejewski, and et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells J Urol 183 2010 2045 2053
7. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550
8. I.B. Barsoum, C.A. Smallwood, D.R. Siemens, and C.H. Graham A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells Cancer Res 74 2014 665 674
9. T.T. Batchelor, E.R. Gerstner, K.E. Emblem, D.G. Duda, J. Kalpathy-Cramer, M. Snuderl, and et al. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation Proc Natl Acad Sci U S A 110 2013 19059 19064
10. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554
11. C. Bayer, K. Shi, S.T. Astner, C.A. Maftei, and P. Vaupel Acute versus chronic hypoxia: Why a simplified classification is simply not enough Int J Radiat Oncol Biol Phys 80 2011 965 968
12. I. Ben-Porath, M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, A. Regev, and et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat Genet 40 2008 499 507
13. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410
14. P. Bergsjo, and P. Kolstad Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of the cervix Scand J Clin Lab Invest Suppl 106 1968 167 171
15. A.S. Betof, C.D. Lascola, D. Weitzel, C. Landon, P.M. Scarbrough, G.R. Devi, and et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise J Natl Cancer Inst 107 2015 djv040
16. J.L. Boddy, S.B. Fox, C. Han, L. Campo, H. Turley, S. Kanga, and et al. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clin Cancer Res 11 2005 7658 7663
17. Y. Boucher, L.T. Baxter, and R.K. Jain Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy Cancer Res 50 1990 4478 4484
18. T. Breidahl, F.U. Nielsen, H. Stodkilde-Jorgensen, R.J. Maxwell, and M.R. Horsman The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS Acta Oncol 45 2006 306 316
19. R.G. Bristow, and R.P. Hill Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability Nat Rev Cancer 8 2008 180 192
20. D.M. Brizel, T. Schroeder, R.L. Scher, S. Walenta, R.W. Clough, M.W. Dewhirst, and et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 349 353
21. D.M. Brizel, G.S. Sibley, L.R. Prosnitz, R.L. Scher, and M.W. Dewhirst Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
22. J.M. Brown The potential benefit of hypoxic cytotoxins in radio-oncology M. Molls, P. Vaupel, Medical Radiology 1998 Springer-Verlag Heidelberg 219 229
23. J.C. Brown, K. Winters-Stone, A. Lee, and K.H. Schmitz Cancer, physical activity, and exercise Compr Physiol 2 2012 2775 2809
24. J.A. Burger, D.J. Stewart, O. Wald, and A. Peled Potential of CXCR4 antagonists for the treatment of metastatic lung cancer Expert Rev Anticancer Ther 11 2011 621 630
25. R.A. Cairns, and R.P. Hill Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma Cancer Res 64 2004 2054 2061
26. Centers for Disease Control and Prevention Adult participation in aerobic and muscle-strengthening physical activities - United States, 2011 Morb Mortal Wkly Rep 62 2013 326 330
27. N. Chan, and R.G. Bristow "Contextual" synthetic lethality and/or loss of heterozygosity: Tumor hypoxia and modification of DNA repair Clin Cancer Res 16 2010 4553 4560
28. D.J. Chaplin, M.R. Horsman, and D.W. Siemann Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: Importance of nicotinamide dose and pre-irradiation breathing time Br J Cancer 68 1993 269 273
29. D.J. Chaplin, P.L. Olive, and R.E. Durand Intermittent blood flow in a murine tumor: Radiobiological effects Cancer Res 47 1987 597 601
30. N. Chaudary, and R.P. Hill Hypoxia and metastasis in breast cancer Breast Dis 26 2006 55 64
31. N. Chaudary, and R.P. Hill Hypoxia and metastasis Clin Cancer Res 13 2007 1947 1949
32. S.S. Chauhan, L.J. Goldstein, and M.M. Gottesman Expression of cathepsin L in human tumors Cancer Res 51 1991 1478 1481
33. F.C. Cheng, M.L. Sheu, H.L. Su, Y.J. Chen, C.J. Chen, W.T. Chiu, and et al. The effect of exercise on mobilization of hematopoietic progenitor cells involved in the repair of sciatic nerve crush injury J Neurosurg 118 2013 594 605
34. T. Cherry A theory of cancer Med J Aust 1 1922 425 438
35. I. Churchill-Davidson The oxygen effect in radiotherapy: Historical review Front Radiat Ther Oncol 1 1968 1 15
36. L.A. Cohen, E. Boylan, M. Epstein, and E. Zang Voluntary exercise and experimental mammary cancer Adv Exp Med Biol 322 1992 41 59
37. K.L. Covello, J. Kehler, H. Yu, J.D. Gordan, A.M. Arsham, C.J. Hu, and et al. HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes Dev 20 2006 557 570
38. R.L. Cowen, A.V. Patterson, B.A. Telfer, R.E. Airley, S. Hobbs, R.M. Phillips, and et al. Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts Mol Cancer Ther 2 2003 901 909
39. Y. Dai, K. Bae, C. Pampo, and D.W. Siemann Impact of the small molecule Met inhibitor BMS-777607 on the metastatic process in a rodent tumor model with constitutive c-Met activation Clin Exp Metastasis 29 2012 253 261
40. Y. Dai, K. Bae, and D.W. Siemann Impact of hypoxia on the metastatic potential of human prostate cancer cells Int J Radiat Oncol Biol Phys 81 2011 521 528
41. J. Denekamp, and B. Hobson Endothelial-cell proliferation in experimental tumours Br J Cancer 46 1982 711 720
42. A. Digklia, and I.A. Voutsadakis Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status World J Exp Med 4 2014 58 67
43. S. Dische Hyperbaric oxygen: The Medical Research Council trials and their clinical significance Br J Radiol 51 1978 888 894
44. S. Dische, D. Chassagne, H.F. Hope-Stone, P.J.D. Dawes, K. Roberts, J.T. Yosef, and et al. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: An interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix Radiother Oncol 26 1993 93 103
45. W. Dobrowsky, N.G. Huigol, R.S. Jayatilake, N.I. Kizilbash, S. Okkan, V.T. Kagiya, and et al. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: Results of an IAEA multicentre randomised trial Radiother Oncol 82 2007 24 29
46. J. Drevs, R. Muller-Driver, C. Wittig, S. Fuxius, N. Esser, H. Hugenschmidt, and et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging Cancer Res 62 2002 4015 4022
47. J.X. Duan, H. Jiao, J. Kaizerman, T. Stanton, J.W. Evans, L. Lan, and et al. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs J Med Chem 51 2008 2412 2420
48. L.A. Dusault The effect of oxygen on the response of spontaneous tumours in mice to radiotherapy Br J Radiol 36 1963 749 754
49. J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, and R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239
50. H.P. Eikesdal, W. Landuyt, and O. Dahl The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas Cancer Lett 178 2002 209 217
51. F. Eschwege, H. Sancho-Garnier, D. Chassagne, D. Brisgand, M. Guerra, E.P. Malaise, and et al. Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas Int J Radiat Oncol Biol Phys 39 1997 275 281
52. J.C. Evans, and P. Bergsjo The influence of anemia on the results of radiotherapy in carcinoma of the cervix Radiology 84 1965 709 717
53. V. Everts, W. Korper, K.A. Hoeben, I.D. Jansen, D. Bromme, K.B. Cleutjens, and et al. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: Differences between calvaria and long bone J Bone Miner Res 21 2006 1399 1408
54. C. Fehrer, R. Brunauer, G. Laschober, H. Unterluggauer, S. Reitinger, F. Kloss, and et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan Aging Cell 6 2007 745 757
55. B.M. Fenton, S.F. Paoni, and I. Ding Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors Cancer Res 64 2004 5712 5719
56. N. Ferrara, and R.S. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974
57. J. Folkman How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture Cancer Res 46 1986 467 473
58. D. Fukumura, and R.K. Jain Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize J Cell Biochem 101 2007 937 949
59. L. Garfinkel, and S.D. Stellman Mortality by relative weight and exercise Cancer 62 1988 1844 1850
60. D. Generali, A. Berruti, M.P. Brizzi, L. Campo, S. Bonardi, S. Wigfield, and et al. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer Clin Cancer Res 12 2006 4562 4568
61. L.E. Gerweck, T.G. Nygaard, and M. Burlett Response of cells to hyperthermia under acute and chronic hypoxic conditions Cancer Res 39 1979 966 972
62. Z. Gholamnezhad, M.H. Boskabady, M. Hosseini, M. Sankian, and A. Khajavi Rad Evaluation of immune response after moderate and overtraining exercise in Wistar rat Iran J Basic Med Sci 17 2014 1 8
63. A.J. Giaccia Hypoxic stress proteins: Survival of the fittest Semin Radiat Oncol 6 1996 46 58
64. V. Gocheva, W. Zeng, D. Ke, D. Klimstra, T. Reinheckel, C. Peters, and et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis Genes Dev 20 2006 543 556
65. H. Gong, C. Pottgen, G. Stuben, W. Havers, M. Stuschke, and L. Schweigerer Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation Int J Cancer 106 2003 723 728
66. L. Goretzki, M. Schmitt, K. Mann, J. Calvete, N. Chucholowski, M. Kramer, and et al. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L FEBS Lett 297 1992 112 118
67. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
68. C. Grau, M.R. Horsman, and J. Overgaard Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing Int J Radiat Oncol Biol Phys 22 1992 415 419
69. C. Grau, and J. Overgaard Significance of haemoglobin concentration for treatment outcome M. Molls, P. Vaupel, Medical Radiology: Blood Perfusion and Microenvironment of Human Tumours 1998 Springer-Verlag Heidelberg 101 112
70. L.H. Gray, A.D. Conger, M. Ebert, S. Hornsey, and O.C. Scott The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 1953 638 648
71. M.J. Gray, J. Zhang, L.M. Ellis, G.L. Semenza, D.B. Evans, S.S. Watowich, and et al. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas Oncogene 24 2005 3110 3120
72. M. Grogan, G.M. Thomas, I. Melamed, F.L. Wong, R.G. Pearcey, P.K. Joseph, and et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
73. C.P. Guise, M.R. Abbattista, S.R. Tipparaju, N.K. Lambie, J. Su, D. Li, and et al. Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia Mol Pharmacol 81 2012 31 40
74. C.P. Guise, A.M. Mowday, A. Ashoorzadeh, R. Yuan, W.H. Lin, D.H. Wu, and et al. Bioreductive prodrugs as cancer therapeutics: Targeting tumor hypoxia Chin J Cancer 33 2014 80 86
75. P.B. Gupta, C.L. Chaffer, and R.A. Weinberg Cancer stem cells: Mirage or reality? Nat Med 15 2009 1010 1012
76. R. Gutmann, M. Leunig, J. Feyh, A.E. Goetz, K. Messmer, E. Kastenbauer, and et al. Interstitial hypertension in head and neck tumors in patients: Correlation with tumor size Cancer Res 52 1992 1993 1995
77. S. Hara, K. Nakashiro, S.K. Klosek, T. Ishikawa, S. Shintani, and H. Hamakawa Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells Oral Oncol 42 2006 593 598
78. S.M. Hatfield, J. Kjaergaard, D. Lukashev, T.H. Schreiber, B. Belikoff, R. Abbott, and et al. Immunological mechanisms of the antitumor effects of supplemental oxygenation Sci Transl Med 7 2015 277ra230
79. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation Nat Med 3 1997 177 182
80. M. Hiraoka, and G.M. Hahn Changes in pH and blood flow induced by glucose, and their effects on hyperthermia with or without BCNU in RIF-1 tumours Int J Hyperthermia 6 1990 97 103
81. D.G. Hirst, and P.J. Wood Could manipulation of the binding affinity of haemoglobin for oxygen be used clinically to sensitize tumours to radiation? Radiother Oncol 20 Suppl. 1 1991 53 57
82. 2 predicts survival in advanced cancer of the uterine cervix Radiother Oncol 26 1993 45 50
83. C.M. Hoff Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy Acta Oncol 51 2012 419 432
84. M.R. Horsman Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review Acta Oncol 34 1995 571 587
85. M.R. Horsman Measurement of tumor oxygenation Int J Radiat Oncol Biol Phys 42 1998 701 704
86. M.R. Horsman Tissue physiology and the response to heat Int J Hyperthermia 22 2006 197 203
87. M.R. Horsman, K.L. Christensen, and J. Overgaard Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo Int J Hyperthermia 5 1989 123 136
88. M.R. Horsman, L.S. Mortensen, J.B. Petersen, M. Busk, and J. Overgaard Imaging hypoxia to improve radiotherapy outcome Nat Rev Clin Oncol 9 2012 674 687
89. M.R. Horsman, and J. Overgaard Hyperthermia: A potent enhancer of radiotherapy Clin Oncol 19 2007 418 426
90. M.R. Horsman, J. Overgaard, and D.W. Siemann Impact on radiotherapy D.W. Siemann, Tumor Microenvironment 2011 John Wiley & Sons, Ltd. Chichester 353 376
91. M.R. Horsman, and D.W. Siemann Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies Cancer Res 66 2006 11520 11539
92. P.J. Hoskin, M. Robinson, N. Slevin, D. Morgan, K. Harrington, and C. Gaffney Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer J Clin Oncol 27 2009 5751 5756
93. P.J. Hoskin, A.M. Rojas, S.M. Bentzen, and M.I. Saunders Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma J Clin Oncol 28 2010 4912 4918
94. E.P. Hui, A.T. Chan, F. Pezzella, H. Turley, K.F. To, T.C. Poon, B. Zee, F. Mo, P.M. Teo, D.P. Huang, K.C. Gatter, P.J. Johnson, and A.L. Harris Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival Clin Cancer Res 8 2002 2595 2604
95. J.H. Hwang, H.J. Chang, Y.H. Shim, W.H. Park, W. Park, S.J. Huh, and et al. Effects of supervised exercise therapy in patients receiving radiotherapy for breast cancer Yonsei Med J 49 2008 443 450
96. A.B. Iversen, M. Busk, and M.R. Horsman Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy Acta Oncol 52 2013 1320 1326
97. M. Jagodic, I. Vrhovec, S. Borstnar, and T. Cufer Prognostic and predictive value of cathepsins D and L in operable breast cancer patients Neoplasma 52 2005 1 9
98. R.K. Jain Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy Nat Med 7 2001 987 989
99. R.K. Jain Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia Cancer Cell 26 2014 605 622
100. G.O. Janssens, S.E. Rademakers, C.H. Terhaard, P.A. Doornaert, H.P. Bijl, P. van den Ende, and et al. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: Results of a phase III randomized trial J Clin Oncol 30 2012 1777 1783
101. D. Jean, N. Rousselet, and R. Frade Cathepsin L expression is up-regulated by hypoxia in human melanoma cells: Role of its 5′-untranslated region Biochem J 413 2008 125 134
102. L.W. Jones, J. Antonelli, E.M. Masko, G. Broadwater, C.D. Lascola, D. Fels, and et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer J Appl Physiol 113 2012 263 272
103. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 2006 1253 1261
104. J.H. Kaanders, J. Bussink, and A.J. van der Kogel ARCON: A novel biology-based approach in radiotherapy Lancet Oncol 3 2002 728 737
105. 2 sensing and cancer Nat Rev Cancer 8 2008 865 873
106. H.H. Kampinga, and E. Dikomey Hyperthermic radiosensitization: Mode of action and clinical relevance Int J Radiat Biol 77 2001 399 408
107. K. Karasawa, M. Sunamura, A. Okamoto, K. Nemoto, S. Matsuno, Y. Nishimura, and et al. Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study Radiother Oncol 87 2008 326 330
108. B. Keith, R.S. Johnson, and M.C. Simon HIF1alpha and HIF2alpha: Sibling rivalry in hypoxic tumour growth and progression Nat Rev Cancer 12 2012 9 22
109. B. Keith, and M.C. Simon Hypoxia-inducible factors, stem cells, and cancer Cell 129 2007 465 472
110. R.S. Kerbel, and B.A. Kamen The anti-angiogenic basis of metronomic chemotherapy Nat Rev Cancer 4 2004 423 436
111. K.S. Kimbro, and J.W. Simons Hypoxia-inducible factor-1 in human breast and prostate cancer Endocr Relat Cancer 13 2006 739 749
112. H. Kimura, R.D. Braun, E.T. Ong, R. Hsu, T.W. Secomb, D. Papahadjopoulos, and et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma Cancer Res 56 1996 5522 5528
113. D.J. Laird, U.H. von Andrian, and A.J. Wagers Stem cell trafficking in tissue development, growth, and disease Cell 132 2008 612 630
114. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, and et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648
115. J.A. Lee, N.M. Biel, R.T. Kozikowski, D.W. Siemann, and B.S. Sorg In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors Biomed Opt Express 5 2014 1965 1979
116. D.J. Lee, D. Cosmatos, V.A. Marcial, K.K. Fu, M. Rotman, J.S. Cooper, and et al. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas Int J Radiat Oncol Biol Phys 32 1995 567 576
117. J.A. Lee, J. Wiggins, and D.W. Siemann Impact of aerobic exercise on tumor oxygenation and perfusion in breast cancer [abstract] Proceedings of the American Association for Cancer Research Special Conference on Tumor Angiogenesis and Vascular Normalization: Bench to Bedside to Biomarkers (Abstract Nr B24) 2015 AACR Orlando, FL. Philadelphia (PA)
118. Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, and et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
119. J.M. Luis, F. Buricchi, P. Chiarugi, A. Morales, and J.C. Fernandez-Checa Dual role of mitochondrial reactive oxygen species in hypoxia signaling: Activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death Cancer Res 67 2007 7368 7377
120. S.J. Lunt, B.A. Telfer, R.J. Fitzmaurice, I.J. Stratford, and K.J. Williams Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination Clin Cancer Res 11 2005 4212 4216
121. A. Mantovani, P. Romero, A.K. Palucka, and F.M. Marincola Tumour immunity: Effector response to tumour and role of the microenvironment Lancet 371 2008 771 783
122. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, C.M. Pinna, and et al. HIF induces human embryonic stem cell markers in cancer cells Cancer Res 71 2011 4640 4652
123. N.A. Mayr, J.Z. Wang, D. Zhang, J.C. Grecula, S.S. Lo, D. Jaroura, and et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer Int J Radiat Oncol Biol Phys 77 2010 502 508
124. A.M. McCord, M. Jamal, U.T. Shankavaram, F.F. Lang, K. Camphausen, and P.J. Tofilon Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro Mol Cancer Res 7 2009 489 497
125. D.J. McCullough, L.M. Nguyen, D.W. Siemann, and B.J. Behnke Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model J Appl Physiol 115 2013 1846 1854
126. D.J. McCullough, J.N. Stabley, D.W. Siemann, and B.J. Behnke Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise J Natl Cancer Inst 106 2014 dju036
127. S.R. McKeown, R.L. Cowen, and K.J. Williams Bioreductive drugs: From concept to clinic Clin Oncol 19 2007 427 442
128. S.R. McKeown, M.V. Hejmadi, I.A. McIntyre, J.J. McAleer, and L.H. Patterson AQ4N: An alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo Br J Cancer 72 1995 76 81
129. W.M. Mendenhall, C.G. Morris, R.J. Amdur, N.P. Mendenhall, and D.W. Siemann Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: A prospective, randomized trial Cancer 104 2005 332 337
130. F. Meng, J.W. Evans, D. Bhupathi, M. Banica, L. Lan, G. Lorente, and et al. Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302 Mol Cancer Ther 11 2012 740 751
131. M. Milosevic, P. Chung, C. Parker, R. Bristow, A. Toi, T. Panzarella, and et al. Androgen withdrawal in patients reduces prostate cancer hypoxia: Implications for disease progression and radiation response Cancer Res 67 2007 6022 6025
132. M. Milosevic, A. Fyles, D. Hedley, M. Pintilie, W. Levin, L. Manchul, and et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements Cancer Res 61 2001 6400 6405
133. M. Milosevic, P. Warde, C. Menard, P. Chung, A. Toi, A. Ishkanian, and et al. Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer Clin Cancer Res 18 2012 2108 2114
134. A.I. Minchinton, and I.F. Tannock Drug penetration in solid tumours Nat Rev Cancer 6 2006 583 592
135. B. Monk, M. Sill, J. Walker, P. DiSilvestro, G. Sutton, K. Tewari, and et al. Randomized phase 2 evaluation of bevacizumab versus bevacizumab/fosbretabulin in recurrent ovarian, tubal or peritoneal carcinoma: A gynecologic oncology group study [abstract] Int J Gynecol Cancer 24 Suppl. 4 2014 42 43
136. L.S. Mortensen, J. Johansen, J. Kallehauge, H. Primdahl, M. Busk, P. Lassen, and et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial Radiother Oncol 105 2012 14 20
137. J.E. Moulder, and S. Rockwell Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data Int J Radiat Oncol Biol Phys 10 1984 695 712
138. 2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings Urology 60 2002 634 639
139. D. Mukhopadhyay, L. Tsiokas, X.M. Zhou, D. Foster, J.S. Brugge, and V.P. Sukhatme Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature 375 1995 577 581
140. K.M. Mustian, L. Peppone, T.V. Darling, O. Palesh, C.E. Heckler, and G.R. Morrow A 4-week home-based aerobic and resistance exercise program during radiation therapy: A pilot randomized clinical trial J Support Oncol 7 2009 158 167
141. T. Nielsen, R. Murata, R.J. Maxwell, H. Stodkilde-Jorgensen, L. Ostergaard, C.D. Ley, and et al. Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates Acta Oncol 49 2010 906 913
142. M. Nordsmark, S.M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, P. Stadler, and et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
143. J. Overgaard Sensitization of hypoxic tumour cells - clinical experience Int J Radiat Biol 56 1989 801 811
144. J. Overgaard Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors Oncol Res 6 1994 509 518
145. J. Overgaard, and P. Bichel The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro Radiology 123 1977 511 514
146. J. Overgaard, H.S. Hansen, M. Overgaard, L. Bastholt, A. Berthelsen, L. Specht, and et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Radiother Oncol 46 1998 135 146
147. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, and et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
148. R.S. Paffenbarger Jr., R.T. Hyde, and A.L. Wing Physical activity and incidence of cancer in diverse populations: A preliminary report Am J Clin Nutr 45 1987 312 317
149. A.V. Patterson, D.M. Ferry, S.J. Edmunds, Y. Gu, R.S. Singleton, K. Patel, and et al. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104 Clin Cancer Res 13 2007 3922 3932
150. L.H. Patterson, and S.R. McKeown AQ4N: A new approach to hypoxia-activated cancer chemotherapy Br J Cancer 83 2000 1589 1593
151. B.K. Pedersen, and L. Hoffman-Goetz Exercise and the immune system: Regulation, integration, and adaptation Physiol Rev 80 2000 1055 1081
152. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, and P.M. Comoglio Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 2003 347 361
153. C. Petersen, D. Zips, M. Krause, K. Schone, W. Eicheler, C. Hoinkis, and et al. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation Int J Radiat Oncol Biol Phys 51 2001 483 493
154. I. Petit, D. Jin, and S. Rafii The SDF-1-CXCR4 signaling pathway: A molecular hub modulating neo-angiogenesis Trends Immunol 28 2007 299 307
155. A.M. Petit, J. Rak, M.C. Hung, P. Rockwell, N. Goldstein, B. Fendly, and et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors Am J Pathol 151 1997 1523 1530
156. N.A. Pham, J.M. Magalhaes, T. Do, J. Schwock, N. Dhani, P.J. Cao, and et al. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models Int J Cancer 124 2009 280 286
157. C. Phillips Guidelines urge exercise for cancer patients, survivors NCI Cancer Bulletin 2010 National Cancer Institute Bethesda, MD
158. G. Pitson, A. Fyles, M. Milosevic, J. Wylie, M. Pintilie, and R. Hill Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer Int J Radiat Oncol Biol Phys 51 2001 699 703
159. G. Qing, and M.C. Simon Hypoxia inducible factor-2alpha: A critical mediator of aggressive tumor phenotypes Curr Opin Genet Dev 19 2009 60 66
160. S.E. Rademakers, P.N. Span, J.H. Kaanders, F.C. Sweep, A.J. van der Kogel, and J. Bussink Molecular aspects of tumour hypoxia Mol Oncol 2 2008 41 53
161. A.M. Rauth, R.A. McClelland, H.B. Michaels, and R. Battistella The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system Int J Radiat Oncol Biol Phys 10 1984 1323 1326
162. A.R. Reynolds, I.R. Hart, A.R. Watson, J.C. Welti, R.G. Silva, S.D. Robinson, and et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors Nat Med 15 2009 392 400
163. L. Rice, S. Lepler, C. Pampo, and D.W. Siemann Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells Clin Exp Metastasis 29 2012 133 142
164. S. Rockwell Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor Int J Radiat Oncol Biol Phys 11 1985 97 103
165. S. Rockwell Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro Int J Cancer 38 1986 229 235
166. E.K. Rofstad, K. Galappathi, B. Mathiesen, and E.B. Ruud Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis Clin Cancer Res 13 2007 1971 1978
167. A. Rojas Radiosensitization with normobaric oxygen and carbogen Radiother Oncol 20 Suppl. 1 1991 65 70
168. A. Romiti, M.C. Cox, I. Sarcina, R. Di Rocco, C. D'Antonio, V. Barucca, and et al. Metronomic chemotherapy for cancer treatment: A decade of clinical studies Cancer Chemother Pharmacol 72 2013 13 33
169. J.L. Roti Roti Introduction: Radiosensitization by hyperthermia Int J Hyperthermia 20 2004 109 114
170. P. Rubin, J. Hanley, H.M. Keys, V. Marcial, and L. Brady Carbogen breathing during radiation therapy - The Radiation Therapy Oncology Group Study Int J Radiat Oncol Biol Phys 5 1979 1963 1970
171. Y. Sakaguchi, Y. Maehara, H. Baba, T. Kusumoto, K. Sugimachi, and R.A. Newman Flavone acetic acid increases the antitumor effect of hyperthermia in mice Cancer Res 52 1992 3306 3309
172. A.C. Sartorelli Therapeutic attack of hypoxic cells of solid tumors: Presidential address Cancer Res 48 1988 775 778
173. M.P. Saunders, M. Jaffar, A.V. Patterson, J. Nolan, M.A. Naylor, R.M. Phillips, and et al. The relative importance of NADPH: Cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions Biochem Pharmacol 59 2000 993 996
174. D.D. Schlaepfer, and S.K. Mitra Multiple connections link FAK to cell motility and invasion Curr Opin Genet Dev 14 2004 92 101
175. K.H. Schmitz, K.S. Courneya, C. Matthews, W. Demark-Wahnefried, D.A. Galvao, B.M. Pinto, and et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors Med Sci Sports Exerc 42 2010 1409 1426
176. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
177. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
178. D.W. Siemann Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872 Radiother Oncol 34 1995 47 53
179. D.W. Siemann The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents Cancer Treat Rev 37 2011 63 74
180. D.W. Siemann, and K.L. Alliet Potentiation of CCNU activity by misonidazole in metastases Clin Exp Metastasis 5 1987 57 63
181. D.W. Siemann, Y. Dai, and M.R. Horsman Hypoxia, metastasis, and antiangiogenic therapies G. Melillo, Hypoxia and Cancer: Biological Implications and Therapeutic Opportunities 2014 Springer New York 205 227
182. D.W. Siemann, M. Dong, C. Pampo, and W. Shi Src-signaling interference impairs the dissemination of blood-borne tumor cells Cell Tissue Res 349 2012 541 550
183. 2) on the in vivo radiation response of a murine sarcoma Int J Radiat Oncol Biol Phys 2 1977 903 911
184. D.W. Siemann, and M.R. Horsman Vascular targeted therapies in oncology Cell Tissue Res 335 2009 241 248
185. D.W. Siemann, and L.M. Macler Tumor radiosensitization through reductions in hemoglobin affinity Int J Radiat Oncol Biol Phys 12 1986 1295 1297
186. D.W. Siemann, and R.T. Mulcahy Sensitization of cancer chemotherapeutic agents by nitroheterocyclics Biochem Pharmacol 35 1986 111 115
187. D.W. Siemann, and W. Shi Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors Int J Radiat Oncol Biol Phys 60 2004 1233 1240
188. D.W. Siemann, and W. Shi Dual targeting of tumor vasculature: Combining Avastin and vascular disrupting agents (CA4P or OXi4503) Anticancer Res 28 2008 2027 2031
189. D.W. Siemann, K.H. Warrington, and M.R. Horsman Targeting tumor blood vessels: An adjuvant strategy for radiation therapy Radiother Oncol 57 2000 5 12
190. J.V. Skliarenko, S.J. Lunt, M.L. Gordon, A. Vitkin, M. Milosevic, and R.P. Hill Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors Cancer Res 66 2006 2074 2080
191. J. Sleeman, and P.S. Steeg Cancer metastasis as a therapeutic target Eur J Cancer 46 2010 1177 1180
192. P.S. Steeg Tumor metastasis: Mechanistic insights and clinical challenges Nat Med 12 2006 895 904
193. G.D. Stewart, J.A. Ross, D.B. McLaren, C.C. Parker, F.K. Habib, and A.C. Riddick The relevance of a hypoxic tumour microenvironment in prostate cancer BJU Int 105 2010 8 13
194. I.J. Stratford, P. O'Neill, P.W. Sheldon, A.R. Silver, J.M. Walling, and G.E. Adams RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions Biochem Pharmacol 35 1986 105 109
195. I.J. Stratford, K.J. Williams, R.L. Cowen, and M. Jaffar Combining bioreductive drugs and radiation for the treatment of solid tumors Semin Radiat Oncol 13 2003 42 52
196. D.R. Sudhan, B.M. Rabaglino, C.E. Wood, and D.W. Siemann Role of cathepsin L in breast cancer angiogenesis [abstract] Proceedings of the American Association for Cancer Research Annual Meeting (Abstract Nr 4185). Philadelphia (PA) 2015
197. D.R. Sudhan, and D.W. Siemann Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells Clin Exp Metastasis 30 2013 891 902
198. H.D. Suit, N. Marshall, and D. Woerner Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma Cancer 30 1972 1154 1158
199. R.M. Sutherland, P. Keng, P.J. Conroy, D. McDermott, B.J. Bareham, and W. Passalacqua In vitro hypoxic cytotoxicity of nitroimidazoles: Uptake and cell cycle phase specificity Int J Radiat Oncol Biol Phys 8 1982 745 748
200. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
201. B.A. Teicher, S.A. Holden, G. Ara, E.A. Sotomayor, Z.D. Huang, Y.N. Chen, and et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents Int J Cancer 57 1994 920 925
202. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
203. G.M. Thomas Raising hemoglobin: An opportunity for increasing survival? Oncology 63 Suppl. 2 2002 19 28
204. R.H. Thomlinson, and L.H. Gray The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 1955 539 549
205. R.T. Tong, Y. Boucher, S.V. Kozin, F. Winkler, D.J. Hicklin, and R.K. Jain Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Res 64 2004 3731 3736
206. T. Torimura, H. Iwamoto, T. Nakamura, H. Koga, T. Ueno, R.S. Kerbel, and et al. Metronomic chemotherapy: Possible clinical application in advanced hepatocellular carcinoma Transl Oncol 6 2013 511 519
207. L. Trusolino, A. Bertotti, and P.M. Comoglio MET signalling: Principles and functions in development, organ regeneration and cancer Nat Rev Mol Cell Biol 11 2010 834 848
208. 2 ratio predicts for outcome in patients with localized prostate cancer: Long-term results Int J Radiat Oncol Biol Phys 82 2012 e433 e439
209. M. Urano Thermochemotherapy: From in vitro and in vivo experiments to potential clinical application M. Urano, E. Douple, Hyperthermia and Oncology 1994 VSP Utrecht, The Netherlands 169 204
210. R. Urtasun, P. Band, J.D. Chapman, M.L. Feldstein, B. Mielke, and C. Fryer Radiation and high-dose metronidazole in supratentorial glioblastomas N Engl J Med 294 1976 1364 1367
211. H. van Waart, M.M. Stuiver, W.H. van Harten, G.S. Sonke, and N.K. Aaronson Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): A randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue BMC Cancer 10 2010 673
212. P. Vaupel Tumor microenvironmental physiology and its implications for radiation oncology Semin Radiat Oncol 14 2004 198 206
213. P. Vaupel Pathophysiology of solid tumors M. Molls, P. Vaupel, C. Nieder, M.S. Anscher, The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies 2009 Springer New York 51 92
214. P. Vaupel Pathophysiology of human tumors S. Osinsky, H. Friese, P. Vaupel, Tumor Hypoxia in the Clinical Setting 2011 National Academy of Sciences Ukraine, Kiev 21 64
215. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review Cancer Res 49 1989 6449 6465
216. P. Vaupel, and S. Osinsky Tumor hypoxia and acidosis, and the response to chemotherapy S. Osinsky, H. Friese, P. Vaupel, Tumor Hypoxia in the Clinical Setting 2011 National Academy of Sciences Ukraine, Kiev 93 110
217. W.D. Voorhees III, and C.F. Babbs Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs Eur J Cancer Clin Oncol 18 1982 1027 1033
218. S. Walenta, and W.F. Mueller-Klieser Lactate: Mirror and motor of tumor malignancy Semin Radiat Oncol 14 2004 267 274
219. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nat Rev Cancer 11 2011 393 410
220. P.M. Windsor, K.F. Nicol, and J. Potter A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma Cancer 101 2004 550 557
221. F. Winkler, S.V. Kozin, R.T. Tong, S.S. Chae, M.F. Booth, I. Garkavtsev, and et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 2004 553 563
222. P.P. Wong, F. Demircioglu, E. Ghazaly, W. Alrawashdeh, M.R. Stratford, C.L. Scudamore, and et al. Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread Cancer Cell 27 2015 123 137
223. D.J. Wong, H. Liu, T.W. Ridky, D. Cassarino, E. Segal, and H.Y. Chang Module map of stem cell genes guides creation of epithelial cancer stem cells Cell Stem Cell 2 2008 333 344
224. I. Zajc, N. Sever, A. Bervar, and T.T. Lah Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines Cancer Lett 187 2002 185 190
225. V.E. Zannella, A. Dal Pra, H. Muaddi, T.D. McKee, S. Stapleton, J. Sykes, and et al. Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response Clin Cancer Res 19 2013 6741 6750
226. E.M. Zeman, J.M. Brown, M.J. Lemmon, V.K. Hirst, and W.W. Lee SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells Int J Radiat Oncol Biol Phys 12 1986 1239 1242
227. L. Zhang, G. Huang, X. Li, Y. Zhang, Y. Jiang, J. Shen, and et al. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1alpha in hepatocellular carcinoma BMC Cancer 13 2013 108
228. P. Zhang, H. Li, X. Tan, L. Chen, and S. Wang Association of metformin use with cancer incidence and mortality: A meta-analysis Cancer Epidemiol 37 2013 207 218
229. D. Zhao, L. Jiang, E.W. Hahn, and R.P. Mason Tumor physiologic response to combretastatin A4 phosphate assessed by MRI Int J Radiat Oncol Biol Phys 62 2005 872 880
230. F. Zhou, J. Hu, J.H. Shao, S.B. Zou, S.L. Shen, and Z.Q. Luo Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts J Cancer Res Clin Oncol 138 2012 1879 1890